| Not Yet Recruiting | PH 2 Pemigatinib in SDH-deficient GIST NCT07434843 | Dana-Farber Cancer Institute | Phase 2 |
| Recruiting | Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors NCT04933669 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Completed | Clinical Outcome of Female Non-gastric Gastrointestinal Stromal Tumor NCT04256226 | Far Eastern Memorial Hospital | — |
| Unknown | A Study on Non-invasive Early Diagnosis of Gastrointestinal Stromal Tumors and Differentiation of Benign and M NCT04143048 | The First Affiliated Hospital with Nanjing Medical University | — |
| Active Not Recruiting | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 | National Cancer Institute (NCI) | Phase 2 |
| Suspended | SSG XXV: The Stop-GIST Trial; Discontinuation of Imatinib in Patients With Oligo-metastatic GIST NCT02924714 | Oslo University Hospital | N/A |
| Completed | Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastat NCT02880020 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Unknown | Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor NCT02931981 | RenJi Hospital | — |
| Completed | Feasibility and Yield of a New 20 G ProCore Needle With Coiled Sheath in the Gastrointestinal Subepithelial Tu NCT02884154 | Pusan National University Hospital | N/A |
| Completed | A Study to Evaluate the Safety of Intuvax Administered Intra-tumorally in Patients With Gastrointestinal Strom NCT02686944 | Mendus | Phase 1 |
| Unknown | the Laparoscopic and Endoscopic Cooperative Surgery of Gastrointestinal Stromal Tumor NCT02763748 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Unknown | A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST NCT02776878 | Peking University Cancer Hospital & Institute | N/A |
| Withdrawn | Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chron NCT02734823 | University of Southern California | — |
| Unknown | Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomi NCT02576080 | Assistance Publique Hopitaux De Marseille | Phase 3 |
| Unknown | Quick Skin Sealant in Closure of Surgical Wound After Laparoscopic Surgery NCT02426762 | First Affiliated Hospital, Sun Yat-Sen University | Phase 2 |
| Terminated | Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy NCT02185937 | Radboud University Medical Center | Phase 1 |
| Completed | Phase Ib Study of SUnitinib Alternating With REgorafenib in Patients With Metastatic and/or Unresectable GIST NCT02164240 | Dana-Farber Cancer Institute | Phase 1 |
| Completed | Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal NCT02103322 | Amneal Pharmaceuticals, LLC | Phase 2 / Phase 3 |
| Unknown | Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST NCT02353052 | Shanghai Zhongshan Hospital | — |
| Completed | Surgery for Locally Unresectable Advanced GISTs Without Metastasis After Imatinib Therapy NCT01865565 | Chang Gung Memorial Hospital | — |
| Completed | Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle NCT01769248 | Northwestern University | N/A |
| Completed | Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cann NCT01643278 | National Cancer Institute (NCI) | Phase 1 |
| Completed | A Clinical Trial to Compare the Pharmacokinetics of Imatinib Mesylate Tablet 400mg (1 Tablet) and Glivec Film- NCT01751919 | Dong-A ST Co., Ltd. | Phase 1 |
| Completed | Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors NCT01560260 | National Cancer Institute (NCI) | Phase 2 |
| Unknown | A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor NCT02336724 | Jiangsu HengRui Medicine Co., Ltd. | Phase 2 |
| Completed | Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor NCT01404650 | SCRI Development Innovations, LLC | Phase 2 |
| Unknown | A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients NCT01389583 | National Health Research Institutes, Taiwan | Phase 2 |
| Completed | EUS-guided Fine Needle Biopsy With a New Core Histology Needle Versus Conventional Fine Needle Aspiration NCT01774162 | University of Alberta | N/A |
| Completed | Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced NCT01154452 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Perioperative Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor NCT01267695 | Peking University | Phase 2 |
| Completed | Regorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor NCT01068769 | Suzanne George, MD | Phase 2 |
| Completed | A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GI NCT01039519 | Synta Pharmaceuticals Corp. | Phase 2 |
| Terminated | Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor NCT00956072 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Completed | Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial NCT00954655 | Alliance for Clinical Trials in Oncology | — |
| Unknown | Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors NCT00777504 | Radboud University Medical Center | Phase 4 |
| Completed | Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor NCT00769782 | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Phase 2 |
| Completed | Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor NCT00764595 | Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Phase 2 |
| Completed | Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST) NCT01110668 | Novartis Pharmaceuticals | Phase 2 |
| Completed | Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer NCT00654160 | Mayo Clinic | Phase 1 |
| Terminated | Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointes NCT00324987 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors NCT00568750 | Swiss Cancer Institute | Phase 2 |
| Terminated | Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors NCT00573404 | Vanderbilt-Ingram Cancer Center | Phase 1 |
| Completed | A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. NCT00428220 | Pfizer | N/A |
| Terminated | Safety And Effectiveness Of Daily Dosing With Sunitinib Or Imatinib In Patients With Gastrointestinal Stromal NCT00372567 | Pfizer | Phase 3 |
| Completed | Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Nec NCT00397384 | National Cancer Institute (NCI) | Phase 1 |
| Active Not Recruiting | Sorafenib in Treating Patients With Malignant Gastrointestinal Stromal Tumor That Progressed During or After P NCT00265798 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Canno NCT00091078 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor NCT00112632 | Technical University of Munich | Phase 2 |
| Completed | Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma NCT00112463 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointe NCT00103168 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Completed | Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot NCT00098579 | National Cancer Institute (NCI) | Phase 1 |
| Completed | CCI-779 in Treating Patients With Soft Tissue Sarcoma or Gastrointestinal Stromal Tumor NCT00087074 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer NCT00087191 | National Cancer Institute (NCI) | N/A |
| Completed | A Study To Assess The Safety And Efficacy Of SU11248 In Patients With Gastrointestinal Stromal Tumor(GIST) NCT00075218 | Pfizer | Phase 3 |
| Completed | Imatinib Mesylate in Treating Patients With Primary Gastrointestinal Stromal Tumor That Has Been Completely Re NCT00041197 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma NCT00041249 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Completed | Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of Childhood NCT00030667 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Neoadjuvant and Adjuvant Imatinib Mesylate in Treating Patients With Primary or Recurrent Malignant Gastrointe NCT00028002 | National Cancer Institute (NCI) | Phase 2 |
| Completed | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid NCT00031681 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Imatinib Mesylate in Treating Patients With Gastrointestinal Stromal Tumor That Has Been Completely Removed Du NCT00025246 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction NCT00025415 | National Cancer Institute (NCI) | Phase 1 |
| Unknown | Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor NCT00685828 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Terminated | Comparison of Two Different Doses of STI571 in Treating Patients With Metastatic or Unresectable Gastrointesti NCT00009906 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor NCT00069940 | Dana-Farber Cancer Institute | Phase 1 |
| Completed | SU5416 in Treating Patients With Advanced, Metastatic, or Recurrent Soft Tissue Sarcomas NCT00005862 | National Cancer Institute (NCI) | Phase 2 |
| Completed | STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma NCT00006357 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 1 / Phase 2 |
| Completed | S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors NCT00005597 | SWOG Cancer Research Network | Phase 2 |
| Completed | Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction NCT00004911 | Northwestern University | Phase 1 / Phase 2 |
| Completed | Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction NCT00004910 | Northwestern University | Phase 1 / Phase 2 |
| Completed | Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery NCT00004895 | Northwestern University | Phase 2 |
| Completed | Nitrocamptothecin in Treating Patients With Soft Tissue Sarcomas NCT00005874 | Astex Pharmaceuticals, Inc. | Phase 2 |
| Completed | Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Can NCT00005049 | NYU Langone Health | Phase 2 |
| Completed | Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue Sarcoma NCT00003939 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| No Longer Available | Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination NCT01613053 | Novartis Pharmaceuticals | — |
| No Longer Available | Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0 NCT03493152 | The University of Texas Health Science Center at San Antonio | — |